Uterus Transplantation
exclusive partnership to conduct this

clinical research

Uterine Factor Infertility (UFI) is a condition that affects women and keeps them from being able to carry pregnancies. This is due to the patient either being born without a uterus or having a uterus that cannot carry regular functions due to impairment caused by diseases. In the MENAT region alone, at least 100,000 women are estimated to be affected by this type of infertility.

At the Sahlengrenska Academy, the University of Gothenburg and the Sahlgrenska University Hospital in Sweden, a research project that aims to provide women with the possibility of having biological children with the aid of a transplanted uterus has been ongoing since 1999. The Swedish research team accomplished its first birth in September 2014 and has performed a total of nine uterus transplants that have resulted in five pregnancies and four live births.

Renowned for its high quality standards, Bellevue was handpicked by the Swedish team for an exclusive partnership in the Middle East, North Africa and Turkey Region to conduct this clinical research.

About the procedure

Both women, the donor and the recipient, will undergo clinical tests to check their stats and ensure they are fit to handle the procedure.

The donor should not be older than 60 and can donate even if having previously given birth via C-Section. The donor can be a friend or a family member such as a mother or an aunt.

The recipient should have viable ovaries. They will have their eggs retrieved, fertilized in vitro (IVF) and frozen. The transplant will then be conducted; the donor will have her uterus retrieved and transplanted into the patient.

The patient will be required to take anti-rejection medication in order for the body to accept the uterus. Once the uterus is well implanted and healed, the frozen embryos will be planted in the hope of leading to a healthy pregnancy.

Approximately one year is needed to ensure that the body is not rejecting the uterus and to ascertain that the patient has reached a stable situation with menstruation and anti-rejection medication. The risk of a miscarriage is greater if the eggs are implanted prematurely.

After one or two pregnancies, the uterus will be removed in order to allow the mother to stop taking anti-rejection drugs.

The Team

Professor Mats Brännström,
team leader

Professor of obstetrics & gynecology at the University
of Gothenburg and Senior specialist and Sahlgrenska
University Hospital.

Has the overriding responsibility for the project in uterus
transplantation and is also a doctoral advisor for doctoral
candidates who are participating in the research.
Mats Brännstrom has been clinically active in the field
of gynecological tumor surgery since 1988 and has been
a professor since 2001. Has been involved in research on
uterus transplantation since 1999.

Dr. Randa Akouri

Physician and post-doctoral fellow. Doctoral dissertation in the area of uterus transplantation, where she showed among other things the first living offspring resulting from a uterus transplantation.

Interviews & Reports

MTV Tahkik on UTX at BMC
Uterus Transplantation
NEW Tv report on UTX at BMC
Uterus Transplantation
Futur TV interview
Uterus Transplantation
Future Tv report on UTX at BMC
Uterus Transplantation